文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

列线图基于 Lasso-Cox 回归建立,用于预测早期肝细胞癌患者的复发情况。

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma.

机构信息

Research Center for Biomedical Resources, Beijing You'an Hospital, Capital Medical University, Beijing, China.

Interventional Therapy Center for Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, China.

出版信息

Front Immunol. 2022 Nov 23;13:1019638. doi: 10.3389/fimmu.2022.1019638. eCollection 2022.


DOI:10.3389/fimmu.2022.1019638
PMID:36505501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9726717/
Abstract

PURPOSE: To investigate the risk factors for recurrence in patients with early-stage hepatocellular carcinoma (HCC) after minimally invasive treatment with curative intent, then to construct a prediction model based on Lasso-Cox regression and visualize the model built. METHODS: Clinical data were collected from 547 patients that received minimally invasive treatment in our hospital from January 1, 2012, to December 31, 2016. Lasso regression was used to screen risk factors for recurrence. Then we established Cox proportional hazard regression model and random survival forest model including several parameters screened by Lasso regression. An optimal model was selected by comparing the values of C-index, then the model was visualized and the nomogram was finally plotted. RESULTS: The variables screened by Lasso regression including age, gender, cirrhosis, tumor number, tumor size, platelet-albumin-bilirubin index (PALBI), and viral load were incorporated in the Cox model and random survival forest model (P<0.05). The C-index of these two models in the training sets was 0.729 and 0.708, and was 0.726 and 0.700 in the validation sets, respectively. So we finally chose Lasso-Cox regression model, and the calibration curve in the validation set performed well, indicating that the model built has a better predictive ability. And then a nomogram was plotted based on the model chosen to visualize the results. CONCLUSIONS: The present study established a nomogram for predicting recurrence in patients with early-stage HCC based on the Lasso-Cox regression model. This nomogram was of some guiding significance for screening populations at high risk of recurrence after treatment, by which doctors can formulate individualized follow-up strategies or treatment protocols according to the predicted risk of relapse for patients to improve the long-term prognosis.

摘要

目的:研究以根治性微创治疗为手段的早期肝细胞癌(HCC)患者复发的风险因素,然后基于 Lasso-Cox 回归构建预测模型并可视化模型。

方法:收集 2012 年 1 月 1 日至 2016 年 12 月 31 日在我院接受微创治疗的 547 例患者的临床资料。采用 Lasso 回归筛选复发的风险因素。然后建立 Cox 比例风险回归模型和随机生存森林模型,包括 Lasso 回归筛选的几个参数。通过比较 C 指数值选择最优模型,然后对模型进行可视化并最终绘制诺模图。

结果:Lasso 回归筛选出的变量包括年龄、性别、肝硬化、肿瘤数量、肿瘤大小、血小板-白蛋白-胆红素指数(PALBI)和病毒载量,这些变量被纳入 Cox 模型和随机生存森林模型(P<0.05)。两个模型在训练集的 C 指数分别为 0.729 和 0.708,验证集的 C 指数分别为 0.726 和 0.700。因此,我们最终选择了 Lasso-Cox 回归模型,验证集的校准曲线表现良好,表明构建的模型具有更好的预测能力。然后根据所选模型绘制了一个诺模图,以可视化结果。

结论:本研究基于 Lasso-Cox 回归模型建立了早期 HCC 患者复发预测的诺模图。该诺模图对筛选治疗后复发高风险人群具有一定的指导意义,医生可以根据患者复发的预测风险制定个体化的随访策略或治疗方案,从而改善患者的长期预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/96ba55c0b12b/fimmu-13-1019638-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/cc0e4707120e/fimmu-13-1019638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/55a1eab19103/fimmu-13-1019638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/5ec4386ea477/fimmu-13-1019638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/7e6acf11dc96/fimmu-13-1019638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/96ba55c0b12b/fimmu-13-1019638-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/cc0e4707120e/fimmu-13-1019638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/55a1eab19103/fimmu-13-1019638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/5ec4386ea477/fimmu-13-1019638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/7e6acf11dc96/fimmu-13-1019638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0081/9726717/96ba55c0b12b/fimmu-13-1019638-g005.jpg

相似文献

[1]
Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma.

Front Immunol. 2022

[2]
Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.

Front Immunol. 2024

[3]
Predicting the unpredictable: a robust nomogram for predicting recurrence in patients with ampullary carcinoma.

BMC Cancer. 2024-2-15

[4]
Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score.

Front Immunol. 2024

[5]
[The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].

Zhonghua Wai Ke Za Zhi. 2018-2-1

[6]
A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.

Aging (Albany NY). 2020-6-30

[7]
Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.

J Gastrointest Surg. 2021-1

[8]
A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.

BMC Cancer. 2021-3-8

[9]
Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.

Front Oncol. 2024-5-10

[10]
15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.

Dis Markers. 2020

引用本文的文献

[1]
Implication of CDKN2A in cuproptosis through defining cuproptosis-related gene signature in ovarian cancer.

J Cancer. 2025-7-24

[2]
Integrated multi-omics analysis reveals diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.

Medicine (Baltimore). 2025-8-15

[3]
A scoring model based on MRI features for predicting early recurrence after surgical resection of hepatocellular carcinoma.

Front Surg. 2025-8-1

[4]
Development and validation of a nomogram for predicting immune-related thyroid dysfunction during immunotherapy in non-small cell lung cancer: a prospective cohort study in China.

Front Immunol. 2025-7-25

[5]
Prediction models after hepatectomy for hepatocellular carcinoma-based ultrasonic radiomics: an observational study.

Eur J Med Res. 2025-8-8

[6]
A predictive model based on immune related genes for diffuse large B cell lymphoma (DLBCL).

Transl Cancer Res. 2025-6-30

[7]
Mechanism of ABCD3 inhibiting colorectal cancer progression by regulating Wnt/β-catenin.

Mol Biol Rep. 2025-7-16

[8]
An interpretable machine learning model for predicting early liver metastasis after pancreatic cancer surgery.

BMC Cancer. 2025-7-1

[9]
Impact of tertiary lymphoid structure-associated biomarkers on pancreatic cancer via a dual-disease analysis of psoriasis and pancreatic cancer.

Discov Oncol. 2025-7-1

[10]
Predicting Short-Term Risk of Cardiovascular Events in the Elderly Population: A Retrospective Study in Shanghai, China.

Clin Interv Aging. 2025-6-12

本文引用的文献

[1]
Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma.

J Oncol. 2021-4-7

[2]
A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.

Front Oncol. 2021-4-29

[3]
Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study.

Eur J Radiol. 2021-5

[4]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[5]
Hepatocellular carcinoma.

Nat Rev Dis Primers. 2021-1-21

[6]
Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.

Int J Hyperthermia. 2021

[7]
Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.

Int J Hyperthermia. 2019

[8]
Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.

PLoS One. 2019-5-2

[9]
Hepatocellular Carcinoma.

N Engl J Med. 2019-4-11

[10]
Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation.

Hepatoma Res. 2018

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索